Location: Princeton, NJ
CIK: 0001907884 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 15, 2026
Total Value: $1.621B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SNDX | SYNDAX PHARMACEUTICALS INC | 8,050,959 | $188M | 11.6% | $17.75 | +17.0% | COM | 87164F105 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 5,840,567 | $185M | 11.4% | $29.50 | -13.9% | COM NEW | 15117B202 |
| PCVX | VAXCYTE INC | 2,922,335 | $170M | 10.5% | $77.50 | -31.9% | COM | 92243G108 |
| COGT | COGENT BIOSCIENCES INC | 4,037,331 | $155M | 9.6% | $7.97 | +369.0% | COM | 19240Q201 |
| VERA | VERA THERAPEUTICS INC | 3,398,224 | $137M | 8.4% | $21.50 | +109.2% | CL A | 92337R101 |
| BEAM | BEAM THERAPEUTICS INC | 3,682,185 | $87.75M | 5.4% | $26.84 | +8.7% | COM | 07373V105 |
| CTMX | CYTOMX THERAPEUTICS INC. | 15,013,093 | $70.56M | 4.4% | $3.91 | +33.8% | COM | 23284F105 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 5,680,795 | $54.08M | 3.3% | $6.82 | +2.6% | COM | 09058V103 |
| TVTX | TRAVERE THERAPEUTICS INC | 1,569,018 | $46.62M | 2.9% | $25.83 | +20.1% | COM | 89422G107 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2,341,652 | $45.8M | 2.8% | $21.98 | +40.3% | COM | 92790C104 |
| CGEM | CULLINAN THERAPEUTICS INC | 3,114,132 | $44.25M | 2.7% | $11.02 | +8.6% | COM | 230031106 |
| URGN | UROGEN PHARMA LTD | 2,247,393 | $40.41M | 2.5% | $20.84 | 0.0% | COM | M96088105 |
| KALV | KALVISTA PHARMACEUTICALS INC | 1,820,954 | $36.66M | 2.3% | $13.44 | +15.3% | COM | 483497103 |
| APLS | APELLIS PHARMACEUTICALS INC | 825,000 | $33.19M | 2.0% | $23.34 | -2.8% | COM | 03753U106 |
| LEGN | LEGEND BIOTECH CORP | 1,576,295 | $28.52M | 1.8% | $18.09 | — | SPONSORED ADS | 52490G102 |
| MBX | MBX BIOSCIENCES INC | 934,799 | $27.9M | 1.7% | $13.37 | +175.5% | COM | 55287L101 |
| IMCR | IMMUNOCORE HLDGS PLC | 884,937 | $26.68M | 1.6% | $29.78 | — | ADS | 45258D105 |
| TVTX | TRAVERE THERAPEUTICS INC | 800,000 | $23.77M | 1.5% | $25.83 | +20.1% | Call | 89422G107 |
| STRO | SUTRO BIOPHARMA INC | 872,558 | $21.74M | 1.3% | $12.01 | +25.6% | COM SHS | 869367201 |
| RVMD | REVOLUTION MEDICINES INC | 207,500 | $20.18M | 1.2% | — | — | Put | 76155X100 |
| BNR | BURNING ROCK BIOTECH LTD | 1,227,555 | $19.79M | 1.2% | $8.24 | — | SPONSORED ADS | 12233L206 |
| SLNO | SOLENO THERAPEUTICS INC | 560,000 | $18.75M | 1.2% | $41.63 | 0.0% | COM | 834203309 |
| NRIX | NURIX THERAPEUTICS INC | 1,194,757 | $18.52M | 1.1% | $12.80 | +35.5% | COM | 67080M103 |
| PHVS | PHARVARIS N V | 640,395 | $18.09M | 1.1% | $22.18 | +20.6% | COM | N69605108 |
| EVMN | EVOMMUNE INC | 625,496 | $14.38M | 0.9% | $21.04 | +4.5% | COM SHS | 30054Y107 |
| RLAY | RELAY THERAPEUTICS INC | 1,424,259 | $14.17M | 0.9% | $4.42 | +88.0% | COM | 75943R102 |
| GERN | GERON CORP | 6,836,318 | $10.19M | 0.6% | $1.98 | -23.7% | COM | 374163103 |
| ENGN | ENGENE HOLDINGS INC | 1,356,843 | $9.24M | 0.6% | $7.65 | +26.3% | COM | 29286M105 |
| DSGN | DESIGN THERAPEUTICS INC | 784,606 | $8.348M | 0.5% | $4.65 | +115.0% | COM | 25056L103 |
| WVE | WAVE LIFE SCIENCES LTD | 965,193 | $6.998M | 0.4% | $4.64 | +196.4% | SHS | Y95308105 |
| CLYM | CLIMB BIO INC | 1,003,341 | $6.873M | 0.4% | $2.66 | +87.5% | COM | 28658R106 |
| AMRN | AMARIN CORP PLC | 472,382 | $6.831M | 0.4% | $15.91 | — | SPONSORED ADR | 023111404 |
| BHVN | BIOHAVEN LTD | 702,884 | $5.946M | 0.4% | $12.39 | -5.1% | COM | G1110E107 |
| PRLD | PRELUDE THERAPEUTICS INC | 1,592,551 | $5.447M | 0.3% | $2.00 | +15.2% | COM | 74065P101 |
| CRBU | CARIBOU BIOSCIENCES INC | 2,503,302 | $4.756M | 0.3% | $3.41 | -52.5% | COM | 142038108 |
| ALEC | ALECTOR INC | 2,000,000 | $4.3M | 0.3% | $1.77 | +7.5% | COM | 014442107 |
| PRQR | PROQR THRAPEUTICS N V | 1,566,317 | $2.537M | 0.2% | $3.18 | -48.5% | SHS EURO | N71542109 |
| TVTX | TRAVERE THERAPEUTICS INC | 54,900 | $1.631M | 0.1% | $25.83 | +20.1% | Put | 89422G107 |
| CADL | CANDEL THERAPEUTICS INC | 200,000 | $980K | 0.1% | $5.74 | 0.0% | COM | 137404109 |